학술논문
Phase 3, multicentre, randomised, placebo-controlled study evaluating the efficacy and safety of ustekinumab in patients with systemic lupus erythematosus.
Document Type
Article
Author
Source
Annals of the Rheumatic Diseases; Nov2022, Vol. 81 Issue 11, p1556-1563, 8p
Subject
Language
ISSN
00034967